Utama › Fibrosis Kistik › Michigan
Kajian klinikal Fibrosis Kistik di Michigan
7 kajian untuk Fibrosis Kistik sedang mencari peserta di lokasi di Michigan.
Bandar di Michigan
Teks kajian rasmi (Bahasa Inggeris)
Phase 2 Study to Assess the Safety and Efficacy of ANG003
- University of Michigan, Michigan Medicine, Ann Arbor
- Wayne State University Harper University Hospital, Detroit
Mengambil pesertaFasa 2
Umur 12 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07450547Streamlined Treatment of Pulmonary Exacerbations in Pediatrics
- University of Michigan Health System, Ann Arbor
Mengambil peserta
Umur 3 hingga 18 · Semua jantina · Dikemas kini 3 Ogo 2026 · NCT06654752Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children
- University of Michigan, Michigan Medicine, Ann Arbor
- Helen DeVos Children's Hospital, Grand Rapids
Mengambil pesertaKajian pemerhatian
Sehingga umur 10 · Semua jantina · Dikemas kini 8 Jul 2026 · NCT04509050Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
- University of Michigan, Michigan Medicine, Ann Arbor
- Helen DeVos Children's Hospital, Grand Rapids
Mengambil pesertaFasa 4
Umur 6 ke atas · Semua jantina · Dikemas kini 8 Jul 2026 · NCT05548283Health Outcomes of Parents With Cystic Fibrosis-Aim 2
- University of Michigan, Ann Arbor
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Nov 2025 · NCT06296394Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
- University of Michigan, Ann Arbor
Mengambil pesertaKajian pemerhatian
Umur 6 ke atas · Semua jantina · Dikemas kini 3 Nov 2025 · NCT06683092A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
- University of Michigan, Michigan Medicine, Ann Arbor
- Wayne State University Harper University Hospital, Detroit
- Corewell Health Helen DeVos, Grand Rapids
Mengambil pesertaKajian pemerhatian
Umur 12 ke atas · Semua jantina · Dikemas kini 1 Okt 2025 · NCT06504589Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.